PMU54 A Claims-Based Algorithm to Identify Inadequate Response to Immunomodulatory Therapies Among Patients with Selected Autoimmune Diseases

To evaluate a claims-based algorithm initially validated for rheumatoid arthritis to identify inadequate response (IR) to advanced therapy (AT) with immunomodulators among patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), Crohn ’s disease (CD), lupus (SLE), and psoriasis (PsO).

Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: M. Grabner, T. Hunter, C.C. Teng, K. Isenberg, R.T. Burge, J. Birt, A. Naegeli, M. Shan, J.R. Curtis Source Type: research